Oncologix Tech Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Oncologix Tech recent Real Value cannot be determined due to lack of data. The prevailing price of Oncologix Tech is $0.0. Our model determines the value of Oncologix Tech from analyzing the company fundamentals such as Return On Asset of -0.12, current valuation of 3.18 M, and Price To Earning of (0.03) X as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Oncologix Tech's price fluctuation is out of control at this time. Calculation of the real value of Oncologix Tech is based on 3 months time horizon. Increasing Oncologix Tech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Oncologix pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Oncologix Tech. Since Oncologix Tech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Oncologix Pink Sheet. However, Oncologix Tech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 | Naive 9.3E-5 |
The real value of Oncologix Pink Sheet, also known as its intrinsic value, is the underlying worth of Oncologix Tech Company, which is reflected in its stock price. It is based on Oncologix Tech's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Oncologix Tech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Oncologix Tech helps investors to forecast how Oncologix pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Oncologix Tech more accurately as focusing exclusively on Oncologix Tech's fundamentals will not take into account other important factors: Oncologix Tech Total Value Analysis
Oncologix Tech is now expected to have valuation of 3.18 M with market capitalization of 612.23 K, debt of 3.97 M, and cash on hands of 86.31 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Oncologix Tech fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.18 M | 612.23 K | 3.97 M | 86.31 K |
Oncologix Tech Investor Information
The company recorded a loss per share of 0.01. Oncologix Tech had not issued any dividends in recent years. The entity had 1:4 split on the 19th of May 2011. Based on the key indicators obtained from Oncologix Tech's historical financial statements, Oncologix Tech is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Oncologix Tech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Oncologix Tech has an asset utilization ratio of 190.63 percent. This implies that the Company is making $1.91 for each dollar of assets. An increasing asset utilization means that Oncologix Tech is more efficient with each dollar of assets it utilizes for everyday operations.Oncologix Tech Profitability Analysis
The company reported the previous year's revenue of 2.85 M. Net Loss for the year was (2.37 M) with profit before overhead, payroll, taxes, and interest of 614.41 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Oncologix Tech's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Oncologix Tech and how it compares across the competition.
About Oncologix Tech Valuation
The pink sheet valuation mechanism determines Oncologix Tech's current worth on a weekly basis. Our valuation model uses a comparative analysis of Oncologix Tech. We calculate exposure to Oncologix Tech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Oncologix Tech's related companies.Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana. Oncologix Tech operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 191 people.
8 Steps to conduct Oncologix Tech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Oncologix Tech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Oncologix Tech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Oncologix Tech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Oncologix Tech's revenue streams: Identify Oncologix Tech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Oncologix Tech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Oncologix Tech's growth potential: Evaluate Oncologix Tech's management, business model, and growth potential.
- Determine Oncologix Tech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Oncologix Tech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Oncologix Tech Growth Indicators
Investing in growth stocks can be very risky. If the company such as Oncologix Tech does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -55.1 M | |
| Shares Float | 736.6 M |
Complementary Tools for Oncologix Pink Sheet analysis
When running Oncologix Tech's price analysis, check to measure Oncologix Tech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncologix Tech is operating at the current time. Most of Oncologix Tech's value examination focuses on studying past and present price action to predict the probability of Oncologix Tech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncologix Tech's price. Additionally, you may evaluate how the addition of Oncologix Tech to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |